Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imfinzi
Imfinzi
AstraZeneca’s Imfinzi Phase III trial raises trial design questions
AstraZeneca’s Imfinzi Phase III trial raises trial design questions
Clinical Trials Arena
AstraZeneca
Imfinzi
clinical trials
Flag link:
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop
BioSpace
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Flag link:
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
Clinical Trials Arena
AstraZeneca
clinical trials
Imfinzi
hepatocellular carcinoma
Flag link:
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Merck's Keytruda nabs FDA nod in biliary tract cancer, catching up with AstraZeneca's Imfinzi
Fierce Pharma
Merck
AstraZeneca
biliary tract cancer
Keytruda
Imfinzi
Flag link:
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
AstraZeneca
Imfinzi
liver cancer
clinical trials
Flag link:
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
Flag link:
AstraZeneca reports positive results from endometrial cancer therapy trial
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
Flag link:
AstraZeneca's drug combo shows positive results in late-stage cancer trial
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
Flag link:
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
Fierce Pharma
AstraZeneca
AACR
Imfinzi
non-small cell lung cancer
Flag link:
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
Endpoints
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
clinical trials
Flag link:
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
Reuters
AstraZeneca
Imfinzi
lung cancer
Flag link:
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Despite Imfinzi fail in lung cancer trial, AZ 'encouraged' by one result: exec
Fierce Pharma
AstraZeneca
Imfinzi
lung cancer
non-small cell lung cancer
Flag link:
AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer
AstraZeneca: FDA Approves Imfinzi Plus Chemotherapy To Treat Biliary Tract Cancer
NASDAQ
AstraZeneca
Imfinzi
biliary tract cancer
FDA
Flag link:
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
AstraZeneca, chasing immunotherapy rivals, claims study success in early lung cancer
BioPharma Dive
AstraZeneca
Imfinzi
clinical trials
non-small cell lung cancer
Flag link:
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool
AstraZeneca
FDA
Imfinzi
tremelimumab
liver cancer
Flag link:
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
Pharmaforum
AstraZeneca
Imfinzi
biliary tract cancer
FDA
priority review
Flag link:
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
Fierce Pharma
AstraZeneca
Ono Pharmaceutical
lung cancer
patents
Imfinzi
Flag link:
AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer
AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer
Pharmaforum
AstraZeneca
Imfinzi
biliary tract cancer
clinical trials
Flag link:
AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer
AstraZeneca: Imfinzi Plus Tremelimumab Improves OS In Phase III Trial In Liver Cancer
NASDAQ
AstraZeneca
liver cancer
clinical trials
Imfinzi
tremelimumab
Flag link:
ESMO 2021 – Astra coasts towards a new lung cancer combo
ESMO 2021 – Astra coasts towards a new lung cancer combo
EP Vantage
ESMO
AstraZeneca
Imfinzi
oleclumab
Innate Pharma
non-small cell lung cancer
Flag link:
Pages
1
2
3
4
next ›
last »